Item 2.01 Completion of Acquisition or Disposition of Assets.
On November 1, 2022, Marpai, Inc. (the "Company") filed a Current Report on Form
8-K (the "Initial Report") to report the Company's consummation of Maestro
Health, LLC ("Maestro Health"), a Delaware limited liability company, pursuant
to the terms of the Membership Interest Purchase Agreement executed by and among
the Company, X.L. America, Inc., a Delaware corporation, Seaview Re Holdings
Inc., a Delaware corporation, and AXA S.A., a French société anonyme.
This Current Report on Form 8-K/A (this "Amendment") amends and supplements the
Initial Report to provide financial statements of Maestro Health, and the pro
forma financial statements of the Company required by Item 9.01 of Form 8-K. No
other modifications to the Initial Report are being made by this Amendment. This
Amendment should be read in conjunction with the Initial Report.
Item 9.01 Financial Statements and Exhibits.
(a) Financial Statements of Business Acquired.
The audited financial statements of Maestro Health as of and for the year ended
December 31, 2021, together with the related notes to the financial statements,
are included as Exhibit 99.1 to this Current Report and are incorporated herein
by reference. The unaudited financial statements of Maestro Health as of and for
the nine months ended September 30, 2022 are included as Exhibit 99.2.
(b) Pro Forma Financial Information.
The unaudited pro forma combined financial statements of the Company as of and
for the year ended December 31, 2021, together with the related unaudited notes
to the financial statements, are included as Exhibit 99.3 to this Current Report
and are incorporated herein by reference.
(d) Exhibits.
Exhibit Description
Number
99.1 Audited financial statements of Maestro Health, LLC as of and for the
year ended December 31, 2021 and 2020.
99.2 Unaudited financial statements of Maestro Health, LLC as of and for
the nine months ended September 30, 2022.
99.3 Unaudited Pro Forma Combined Financial Statements of Marpai, Inc. as
of and for the year ended December 31, 2021, together with the related
notes to the financial statements.
104 Cover Page Interactive Data File (formatted as inline XBRL and contained
in Exhibit 101)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses